Floatz logo

Ethylicum

Cancer-Related Condition

Sindh Institute of Urology and TransplantationSmall moleculePhase 4 / ApprovedDormant
BB
66/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
95/ 100

Competitive context

10 Active assets in the Cancer-Related Condition cohort.

Asset / SponsorPhaseRating
Oxycodone
Deventer Ziekenhuis
Phase 4BB
Lidocaine
National and Kapodistrian University of Athens
Phase 2/3BB
Nepenthe
Instituto Nacional de Cancer, Brazil
Phase 3BB
Dexasone
Montefiore Medical Center
Phase 4BB
Mirtazapine
Montefiore Medical Center
Phase 4BB

View all 20 →

Same molecule, other indications

Ethylicum is also rated in:

malignant pancreatic neoplasmDormant
BB
Indicative · Phase 4
66 / 100
View asset →
pancreatic mucinous-cystic neoplasmDormant
B
Indicative · Phase 2
63 / 100
View asset →
leukemiaDormant
B
Indicative · Phase 4
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →